Creative Planning boosted its stake in Xylem Inc (NYSE:XYL) by 13.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,766 shares of the industrial products company’s stock after purchasing an additional 2,154 shares during the quarter. Creative Planning’s holdings in Xylem were worth $1,499,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Flagship Harbor Advisors LLC purchased a new stake in shares of Xylem in the 2nd quarter valued at about $106,000. Smithfield Trust Co. raised its holdings in shares of Xylem by 1,690.0% in the 2nd quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock valued at $108,000 after acquiring an additional 1,521 shares in the last quarter. Fort L.P. purchased a new stake in shares of Xylem in the 2nd quarter valued at about $118,000. Stelac Advisory Services LLC purchased a new stake in shares of Xylem in the 2nd quarter valued at about $125,000. Finally, Piedmont Investment Advisors LLC purchased a new stake in shares of Xylem in the 2nd quarter valued at about $139,000. Institutional investors and hedge funds own 84.53% of the company’s stock.
Several research firms have weighed in on XYL. BMO Capital Markets lowered their price target on Xylem from $84.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday. Credit Suisse Group lowered their price target on Xylem from $86.00 to $81.00 and set an “outperform” rating on the stock in a report on Wednesday. Seaport Global Securities set a $80.00 price target on Xylem and gave the company a “buy” rating in a report on Wednesday. Royal Bank of Canada reaffirmed a “buy” rating and issued a $77.00 price target on shares of Xylem in a report on Wednesday. Finally, ValuEngine cut Xylem from a “buy” rating to a “hold” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $79.57.
Shares of NYSE XYL opened at $68.75 on Friday. The stock has a market cap of $11.70 billion, a P/E ratio of 28.65, a PEG ratio of 1.25 and a beta of 1.22. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.02 and a current ratio of 1.49. Xylem Inc has a 1-year low of $63.71 and a 1-year high of $82.44.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 30th. The industrial products company reported $0.77 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.77. The company had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.30 billion. Xylem had a return on equity of 19.54% and a net margin of 7.75%. Xylem’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $0.65 EPS. As a group, equities analysts expect that Xylem Inc will post 2.88 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Thursday, November 1st will be issued a dividend of $0.21 per share. The ex-dividend date is Wednesday, October 31st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.22%. Xylem’s dividend payout ratio is 35.00%.
In related news, Director Curtis J. Crawford sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, August 7th. The stock was sold at an average price of $76.26, for a total transaction of $571,950.00. Following the transaction, the director now directly owns 40,421 shares of the company’s stock, valued at approximately $3,082,505.46. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Colin R. Sabol sold 17,161 shares of the firm’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $81.37, for a total value of $1,396,390.57. Following the transaction, the insider now directly owns 41,988 shares in the company, valued at $3,416,563.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,161 shares of company stock worth $2,327,231. 0.81% of the stock is currently owned by insiders.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Featured Story: Outstanding Shares, Buying and Selling Stocks
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.